SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
2021 · EBioMedicine · 166 citations
https://doi.org/10.1016/j.ebiom.2021.103230
L
Line K. Vibholm
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
885
Citations
13
h-index
15
i10-index
Line K. Vibholm is an academic researcher from Aarhus University. The author has contributed to research in topics: COVID-19 Clinical Research Studies & HIV Research and Treatment & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 13, co-authored 20 publications.
ORCID: 0000-0001-8945-1905Papers by this author
worksImpact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
2023 · Nature Medicine · 72 citations
https://doi.org/10.1038/s41591-023-02547-6
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial
2022 · The Lancet Regional Health - Europe · 52 citations
https://doi.org/10.1016/j.lanepe.2022.100539
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
2019 · EBioMedicine · 35 citations
https://doi.org/10.1016/j.ebiom.2019.07.005
Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
2023 · Clinical Neurophysiology · 24 citations
https://doi.org/10.1016/j.clinph.2023.01.010
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
2023 · BMC Immunology · 20 citations
https://doi.org/10.1186/s12865-023-00583-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat